Related Experiment Video

Updated: Nov 11, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K

Biology of Melanoma

Stephen M Ostrowski1, David E Fisher1

  • 1Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett 6, 55 Fruit Street, Boston, MA 02114, USA.

Hematology/Oncology Clinics of North America
|March 24, 2021
PubMed

Insights

Melanoma, a skin cancer from melanocytes, often spreads. Advances in genetics and sequencing reveal key mutations like BRAFV600E and UV damage roles, improving metastatic melanoma treatment.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Melanoma arises from melanocytes and is prone to metastasis.
  • Oncogenic BRAFV600E mutations and ultraviolet radiation are key factors in melanoma development.
  • Next-generation sequencing aids in understanding melanoma's molecular landscape.

Purpose of the Study:

  • To review melanoma formation and molecular events.
  • To discuss the biology of melanoma growth and metastasis.
  • To explore the mechanisms of therapeutic resistance in melanoma.

Main Methods:

  • Review of current literature on melanoma genetics and molecular biology.
  • Analysis of next-generation sequencing data related to melanoma.
  • Examination of targeted therapy and immunotherapy research.

Main Results:

  • BRAFV600E mutations and UV-induced DNA damage are critical in melanoma.
  • Molecular insights have driven advances in targeted therapies and immunotherapy.
  • Understanding melanoma biology is crucial for overcoming treatment resistance.

Conclusions:

  • Targeted therapies and immunotherapy have transformed metastatic melanoma outcomes.
  • Further research into melanoma's molecular underpinnings is essential for improving patient survival.
  • Investigating resistance mechanisms is vital for developing more effective melanoma treatments.
Keywords:
AXLImmunotherapyMAPKMITFMelanocyteMelanoma

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.1K
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K